Union Finance Minister Nirmala Sitharaman announced a major new initiative in the Union Budget 2026, with the central government planning to launch the Bio Pharma Shakti scheme with an outlay of ...

These hubs will be integrated complexes featuring modern hospital infrastructure, advanced diagnostics, and post-care ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

Biopharmaceuticals (biologics) are complex drugs made from living sources, not chemical processes. The government is planning interventions in manufacturing, strategic sectors, healthcare, and advance ...

Finance Minister Nirmala Sitharaman has proposed setting up five medical tourism hubs and launching a ‘Biopharma Shakti ...

Finance Minister Nirmala Sitharaman proposes five medical tourism hubs and a Rs 10,000-crore Biopharma Shakti programme in ...

Budget 2026 lays out a major push to scale domestic biologics and biosimilars manufacturing through new institutes and upgraded infrastructure ...

Finance Minister Nirmala Sitharaman on Sunday proposed a Rs 10,000 crore allocation over the next five years to boost India’s ...

In the opening stretch of her address, Sitharaman unveiled a sweeping set of proposals focused on manufacturing, MSMEs, ...

Finance minister Nirmala Sitharaman, while presenting the Union Budget 2026–27 on Sunday, said that India’s disease burden is ...

Finance Minister Nirmala Sitharaman presented her ninth consecutive Union Budget, calling it a ‘yuva shakti’-driven plan ...

Pharma stocks experienced a significant surge after Finance Minister Nirmala Sitharaman announced the Rs 10,000 crore ...